Tempus AI, Inc.

TEM

Precision medicineBiotech & pharmaceuticalsHealthcare diagnostics

$70.93vs prev close▲+1.65(+2.38%)

$40.7752W Range$97.31

53% from low

+11.93 (+20.22%)Past 1M

Price

ARK Trade PatternPREMIUM

1M Trades

6 sells

Consecutive sells

1M net buy

-$27.0M

≈ -372K shares

Portfolio Weight

4.43%

1M +0.70%p

Holding ETFs

2 ETFs

ARKG · ARKK

Buy · Weight Up

ARK net-bought the stock and the price rose, increasing its portfolio weight.

Shares +17.7% · Market value +52.1% · Weight +0.70%p

Trade Intensity

Concentrated sells

Basis: 6 sells · 0 buys in 1M · weight +0.70%p increase

Trade Log6-day SELL streak

Date	Action	ETF	Shares	Close	Est. total
26.10.06	SELL	ARKK	8,905	$71.98	$641.0K
26.09.29	SELL	ARKK	128,292	$82.58	$10.6M
26.09.23	SELL	ARKK	90,621	$76.59	$6.9M
26.09.14	SELL	ARKK	87,027	$62.21	$5.4M
26.09.11	SELL	ARKK	34,631	$59.01	$2.0M
26.09.09	SELL	ARKK	22,767	$61.28	$1.4M
26.09.08	SELL	ARKK	68,759	$64.29	$4.4M
26.09.04	SELL	ARKK	20,180	$64.62	$1.3M
26.09.01	SELL	ARKK	250,062	$62.27	$15.6M
26.08.31	SELL	ARKK	169,672	$63.05	$10.7M
26.08.27	SELL	ARKK	59,276	$70.69	$4.2M
26.08.26	SELL	ARKK	181,919	$68.48	$12.5M
26.08.25	SELL	ARKK	57,819	$68.73	$4.0M
26.08.18	BUY	ARKG	35,501	$49.36	$1.8M
26.08.17	BUY	ARKG	22,666	$51.64	$1.2M

10.06SELL

8,905

ARKKClose$71.98Est. total$641.0K

09.29SELL

128,292

ARKKClose$82.58Est. total$10.6M

09.23SELL

90,621

ARKKClose$76.59Est. total$6.9M

09.14SELL

87,027

ARKKClose$62.21Est. total$5.4M

09.11SELL

34,631

ARKKClose$59.01Est. total$2.0M

09.09SELL

22,767

ARKKClose$61.28Est. total$1.4M

09.08SELL

68,759

ARKKClose$64.29Est. total$4.4M

09.04SELL

20,180

ARKKClose$64.62Est. total$1.3M

09.01SELL

250,062

ARKKClose$62.27Est. total$15.6M

08.31SELL

169,672

ARKKClose$63.05Est. total$10.7M

08.27SELL

59,276

ARKKClose$70.69Est. total$4.2M

08.26SELL

181,919

ARKKClose$68.48Est. total$12.5M

08.25SELL

57,819

ARKKClose$68.73Est. total$4.0M

08.18BUY

35,501

ARKGClose$49.36Est. total$1.8M

08.17BUY

22,666

ARKGClose$51.64Est. total$1.2M

1 / 10

Prices estimated from market closing prices on trade dates. Actual execution prices may differ. This is not investment advice.

Stock Timeline

Institutional Holders

1 Holding · 0 Sold · Q4 2025

Based on ARK ETF real-time + 13F quarterly filings

Cathie WoodARK Invest

LIVE

9,184,916

Portfolio Weight

4.43%

in ETF 8.73%

Est. Value

$767M

30D Net

-$31M

13F data may be delayed up to 90 days.

Market Context

Analyst Consensus

※ Analyst opinions are for reference only and do not constitute investment advice. Each securities firm may have different opinions.

Overall Opinion

Buy

Strong Buy

Buy

Hold

Sell

Analyst Targets

avg.

$72.72

vs Current ▲ +2.5% upside

Current$70.93

Low ~ High$35.00 ~ $100.00

Firm

Position

Price Target

Upside / Downside

Close Price

Action

Date

Guggenheim

Buy

$92.00

+29.71%

$76.50

Maintain

2026-10-01

Goldman Sachs

Neutral

$75.00

+5.74%

$78.03

Upgrade

2026-09-21

HC Wainwright & Co.

Buy

$66.00

-6.95%

$59.01

Maintain

2026-09-11

UBS

Neutral

$70.00

-1.31%

$61.28

Upgrade

2026-09-09

Rothschild & Co

Neutral

$67.00

-5.54%

$64.29

Upgrade

2026-09-08

1 / 4

Avg Target

$72.72

vs Current ▲ +2.5% upside

Buy

20 analysts

Strong Buy 2Buy 8Hold 9Sell 1

Low $35.00

Current $70.93

High $100.00

Firm	Position	Target	Upside	Close	Action	Date
Guggenheim	Buy	$92.00	+29.71%	$76.50	Maintain	26.10.01
Goldman Sachs	Neutral	$75.00	+5.74%	$78.03	Upgrade	26.09.21
HC Wainwright & Co.	Buy	$66.00	-6.95%	$59.01	Maintain	26.09.11
UBS	Neutral	$70.00	-1.31%	$61.28	Upgrade	26.09.09
Rothschild & Co	Neutral	$67.00	-5.54%	$64.29	Upgrade	26.09.08

1 / 4

Price Information

Previous Close$69.28

Open$70.20

Day Range$69.20 - $72.96

52-Week Range$40.77 - $97.31

1-Year Change-24.92%

Trading Volume

Volume6,273,309

Avg Volume (3mo)6,833,970

Valuation

Market Cap12.8B

Book Value$2.47

Shares Outstanding175,390,967

Financials

Revenue (TTM)1.4B

Net Income-254,424,992

EPS$-1.44

EBITDA-202,432,992

Profitability

P/E Ratio-

P/B Ratio28.70

Return on Equity (ROE)-67.44%

Return on Assets (ROA)-8.83%

Profit Margin-17.77%

EV/EBITDA-66.33

Beta3.54

Dividend

Dividend Rate-

Dividend Yield0.00%

Technical

RSI(14)41.44

Company Overview

Tempus AI is a healthcare technology company that provides advanced molecular diagnostics and pathology testing, including next-generation sequencing and PCR profiling. They offer a comprehensive data library and analytical services for pharmaceutical and biotech companies, alongside clinical trial matching and research platforms. Tempus AI positions itself as a leader in precision medicine by integrating clinical, molecular, and imaging data to accelerate drug discovery and improve patient care.

P/B

28.70

High valuation

ROE

-67.4%

Persistent loss

Beta

3.54

Extreme volatility

RSI(14)

41.4

Neutral zone

AI-generated summary. Not investment advice.

Tempus AI, Inc.

Analyst Consensus

Price Information

Trading Volume

Valuation

Financials

Profitability

Dividend

Technical

Related ARK stocks